Interestingly, sphingosyl-phosphorylcholine, which is upregulated in both lesional and non-lesional AD SC [132], has been shown to downregulate FLG mRNA levels in human KCs, presumably via upregulation of intracellular reactive oxygen species (ROS), NADPH oxidase 5, and cyclooxygenase-2 [133], suggesting that lipid abnormalities in AD might regulate filaggrin. The gene discussed is FLG; the disease is Alzheimer disease.